UB Paderborn / Katalog / Suche / in CDI

Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study

European journal of clinical pharmacology, 2022-02, Vol.78 (2), p.227-236

2022

Link zum Volltext

Verfügbarkeit prüfen

How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?

Liječnički vjesnik, 2023-01, Vol.145 (Supp 8), p.43-43

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study

The pharmacogenomics journal, 2020-10, Vol.20 (5), p.638-646

2020

Link zum Volltext

Verfügbarkeit prüfen

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression

Biomolecules (Basel, Switzerland), 2023-09, Vol.13 (9), p.1425

2023

Link zum Volltext

Verfügbarkeit prüfen

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population

Annals of human biology, 2022-11, Vol.49 (7-8), p.323-331

2022

Link zum Volltext

Verfügbarkeit prüfen

UGT2B7 c.-161C>T polymorphism frequency in Croatian population

Arhiv za higijenu rada i toksikologiju, 2022-12, Vol.73 (4), p.303-307

2022

Link zum Volltext

Verfügbarkeit prüfen

Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Genes, 2024-05, Vol.15 (5), p.607

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series

Pharmacy, 2023-02, Vol.11 (1), p.29

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review

Arhiv za higijenu rada i toksikologiju, 2021-06, Vol.72 (2), p.114-128

2021

Link zum Volltext

Verfügbarkeit prüfen

Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppression

The pharmacogenomics journal, 2024-05, Vol.24 (3), p.15-15

2024

Link zum Volltext

Verfügbarkeit prüfen

DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols

British journal of clinical pharmacology, 2022-05, Vol.88 (5), p.2190-2202

2022

Link zum Volltext

Verfügbarkeit prüfen

DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?

Pharmacogenomics, 2023-01, Vol.24 (2), p.93-106

2023

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy

Fundamental & clinical pharmacology, 2024-04, Vol.38 (2), p.351-368

2024

Link zum Volltext

Verfügbarkeit prüfen

Common P-glycoprotein ( ABCB1 ) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data

Biochemia medica, 2024-06, Vol.34 (2), p.020703-020703

2024

Link zum Volltext

Verfügbarkeit prüfen

ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone

Progress in neuro-psychopharmacology & biological psychiatry, 2021-01, Vol.104, p.110042, Article 110042

2021

Link zum Volltext

Verfügbarkeit prüfen

Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A43 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy

European journal of clinical pharmacology, 2023-08, Vol.79 (8), p.1117-1129

2023

Link zum Volltext

Verfügbarkeit prüfen

Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy

British journal of clinical pharmacology, 2018-09, Vol.84 (9), p.2106-2119

2018

Link zum Volltext

Verfügbarkeit prüfen

Is ICYP2C/I Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Genes, 2024-05, Vol.15 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption

Journal of cardiovascular pharmacology, 2020-02, Vol.75 (2), p.174

2020

Link zum Volltext

Verfügbarkeit prüfen

The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study

Psychiatry research, 2019-09, Vol.279, p.389-390

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis

European psychiatry, 2019-09, Vol.61, p.88-96

2019

Link zum Volltext

Verfügbarkeit prüfen

Lack of guidelines and translational knowledge is hindering the implementation of psychiatric genetic counseling and testing within Europe – A multi-professional survey study

European journal of medical genetics, 2023-08, Vol.66 (8), p.104805-104805, Article 104805

2023

Link zum Volltext

Verfügbarkeit prüfen

CYP2C192 genotype influence in acute coronary syndrome patients undergoing serial clopidogrel dose tailoring based on platelet function testing: Analysis from randomized controlled trial NCT02096419

International journal of cardiology, 2015-05, Vol.186, p.282-285

2015

Link zum Volltext

Verfügbarkeit prüfen

Remission Is not Associated with DRD2 rs1800497 and DAT1 rs28363170 Genetic Variants in Male Schizophrenic Patients after 6-months Monotherapy with Olanzapine

Psychiatria Danubina, 2020-01, Vol.32 (1), p.84-91

2020

Link zum Volltext

Verfügbarkeit prüfen

Interakcije lijek-lijek-gen kao posrednici nuspojava diklofenaka i statina – prikaz slučaja i pregled literature

Arhiv za higijenu rada i toksikologiju, 2021-06, Vol.72 (2), p.114

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study

How to conquer tardive dyskinesia: could pharmacogenetics and therapy drug monitoring be useful tools?

Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression

ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population

UGT2B7 c.-161C>T polymorphism frequency in Croatian population

Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series

Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review

Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppression

DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine‐based protocols

DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand?

Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy

Common P-glycoprotein ( ABCB1 ) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data

ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone

Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A43 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy

Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy

Is ICYP2C/I Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?

Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption

The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study

Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis

Lack of guidelines and translational knowledge is hindering the implementation of psychiatric genetic counseling and testing within Europe – A multi-professional survey study

CYP2C192 genotype influence in acute coronary syndrome patients undergoing serial clopidogrel dose tailoring based on platelet function testing: Analysis from randomized controlled trial NCT02096419

Remission Is not Associated with DRD2 rs1800497 and DAT1 rs28363170 Genetic Variants in Male Schizophrenic Patients after 6-months Monotherapy with Olanzapine

Interakcije lijek-lijek-gen kao posrednici nuspojava diklofenaka i statina – prikaz slučaja i pregled literature

Suchergebnisse filtern